Please login to the form below

Not currently logged in
Email:
Password:

personalised medicines

This page shows the latest personalised medicines news and features for those working in and with pharma, biotech and healthcare.

ABPI and AHSN Network targets NHS biomedical innovations uptake

ABPI and AHSN Network targets NHS biomedical innovations uptake

ABPI and AHSN Network targets NHS biomedical innovations uptake. The five year deal covers AI, genomics, personalised medicine and more. ... These areas include economic growth, digital and artificial intelligence, research, genomics and personalised

Latest news

  • GSK: we won’t be splitting up any time soon

    prescription medicines businesses. ... GSK is investing $300m in the firm, and says a long-term partnership to exploit its genetic databases will help it advance personalised medicines research throughout its pipeline.

  • The shifting healthcare landscape The shifting healthcare landscape

    With more personalised medicines targeting specific patient groups, payers cannot apply the old funding approach but need to find new ways to reward innovation. ... Many of these future opportunities rely on companies stepping out of their corner as a

  • The state of trust The state of trust

    There is, however, a trust relationship between government and pharma regarding the production of medicines, but the big problem we have is that pharma doesn’t talk directly to patients. ... Healthy distrust. With the introduction of personalised

  • Revolutionising how healthcare is delivered Revolutionising how healthcare is delivered

    Imagine if a shipment holding medicine that was personalised for the DNA of a cancer patient was spoiled or stolen. ... The complete visibility of healthcare shipments is needed as medicines become more personalised and more potent.

  • NICE: We're the institute of 'yes' NICE: We're the institute of 'yes'

    However, he questioned the industry's current approach to setting out the value offered by new medicines. ... Personalised medicine challenges. The QuintilesIMS meeting also discussed the scale of the health technology assessment challenge presented by

More from news
Approximately 14 fully matching, plus 59 partially matching documents found.

Latest Intelligence

  • Immuno-oncology is fundamentally changing what value means, but how quickly can the pharma marketing, educational and service model change to reflect that? Immuno-oncology is fundamentally changing what value means, but how quickly can the pharma marketing, educational and service model change to reflect that?

    In recent years, biosimilars (highly similar copies of biologic medicines) have taken large shares of many markets. ... It follows that the next generation of relationship holders, representing very expensive but ultra-personalised medicines like CAR-Ts

  • Patently unclear? Patently unclear?

    Another example of such obstacles is the question of whether you can get patent protection for methods of diagnosing disease and for personalised medicine. ... It appears that the situation is still evolving and that for the time being getting patent

  • Real-world evidence Real-world evidence

    work to answer important clinical questions (which may have not been possible otherwise), and it can support the development of evidence-based personalised medicines through the linking of electronic medical records

  • Stronger together Stronger together

    Most recently the European Medicines Agency raised its expectations of pharmaceutical companies, calling for closer integration of patients' views when it issued new guidance last month on the use of ... As new medical technologies like stem cells and

  • It's behind you! It's behind you!

    The advent of smart contact lenses, wearable technologies and personalised medicines offer a tantalising glimpse into the future and how we may understand and assess the patient.

More from intelligence
Approximately 4 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Mastering the precision medicine opportunity

    Personalised: Developing and choosing medicines that will change the patient experience, from one of hope to one of certainty of response. ... In personalised medicine, we ask if we can use a particular treatment in a patient.

  • Medopad: the up and coming unicorn transforming remote patient monitoring

    The company has developed a platform for creating modular apps which can be personalised across numerous patient cohorts, using a combination of artificial intelligence, rich data analysis and a strong understanding ... Tailored care. Healthcare is

  • Medicines personalised for Tom, Dick and Harry

    Medicines personalised for Tom, Dick and Harry. Dorothy may have finally got home to Kansas, but are we doomed to keep following the Yellow Brick Road? ... And so enters the concept of personalised medicine with the aim of providing treatments to

  • Being Human - The healthcare angle

    The industry is busily developing innovative, often personalised medicines, but we’ re under unprecedented scrutiny.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics